Home ProductsCutting Cycle Steroids

Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate

China Hubei Holy Biological Co., Ltd. certification
China Hubei Holy Biological Co., Ltd. certification
I'm Online Chat Now

Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate

Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate
Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate

Large Image :  Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate

Product Details:
Place of Origin: China
Brand Name: Holybiological
Certification: ISO9001 SGS
Model Number: 475207-59-1
Payment & Shipping Terms:
Minimum Order Quantity: 10g
Price: USD1/g
Packaging Details: Aluminum foil bag or as required
Delivery Time: within 24 hours after payment
Payment Terms: Western Union, MoneyGram, T/T
Supply Ability: 300kg/month

Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate

Keyword: Sorafenib Tosylate Alias: Nexavar
CAS: 475207-59-1 Stock: In Stock
Appearance: White Powder Application: Inhibitor Drug
High Light:

safe anabolic steroid


popular anabolic steroids

Anti-cancer Pharmaceuticals White Powder Inhibitor Drug Nexavar Sorafenib Tosylate


Sorafenib tosylate
Synonyms: SORAFENIB TOSYLATE;Sorafenib & its intermediates;Sorafinib mesylate;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate;Sorafenib Tosylate(Bay 43-9006,Nexavar);2-PyridinecarboxaMide, 4-[4-[[[[4-chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]phenoxy]-N-Methyl-, 4-Methylbenzenesulfonate;Sorafenib Tosylate (Nexavar);Sorafenib (Nexavar)
CAS: 475207-59-1
MF: C21H16ClF3N4O3.C7H8SO3
MW: 637.03
Product Categories: Bay 43-9006
Usage Sorafenib Tosylate (Bay 43-9006, Nexavar) is a small molecular inhibitor of VEGFR, PDGFR, c-Raf and B-Raf with IC50s of 18 nM, 10 nM, 3 nM and 15 nM, respectively.
Usage Sorafenib Tosylate (Bay 43-9006) is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively



Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.

At the current time sorafenib is indicated as a treatment for advanced renal cell carcinoma (RCC), unresectable hepatocellular carcinomas (HCC) and thyroid cancer


product Name Sorafenib tosylate
Synonyms SORAFENIB-D3; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea Tolsylate
Molecular Formula C21H16ClF3N4O3・C7H8SO
Molecular Weight 637.03
CAS Registry Number 475207-59-1;4750207-59-1
Molecular Structure Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate 0


Anticancer Drugs Cutting Cycle Steroids 475207 59 1 Sorafenib Tosylate 1



toluenesulfonic Sorafenib is a novel multi-target anticancer drugs, can act simultaneously on tumor cells and tumor blood vessels. It has a dual The anti-tumor effect: either by blocking the RAF / MEK / ERK-mediated cell signaling pathways and direct inhibition of tumor cell proliferation, but also By inhibiting VEGF and platelet-derived Health growth factor (PDGF) receptors and block the formation of tumor angiogenesis, indirectly inhibit the growth of tumor cells


Sorafenib is used for:

Treating certain types of kidney, liver or thyroid cancer. It may also be used for other conditions as determined by your doctor.

Sorafenib is a multikinase inhibitor. It works by helping to stop cancer cells from growing.

Do NOT use sorafenib if:
you are allergic to any ingredient in sorafenib
you have a certain type of irregular heartbeat (congenital long QT syndrome)
you have a certain type of lung cancer (squamous cell) and are taking carboplatin and paclitaxel
Contact your doctor or health care provider right away if any of these apply to you.


Before using sorafenib:

Some medical conditions may interact with sorafenib. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding
if you are able to become pregnant
if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
if you have allergies to medicines, foods, or other substances
you have heart failure or other heart problems (eg, irregular heartbeat, disease of the blood vessels in the heart, a recent heart attack)
if you have chest pain; high blood pressure; bleeding problems; blood electrolyte problems (eg, low blood calcium, magnesium, or potassium levels); stomach or bowel problems (eg, tearing); or liver, kidney, or thyroid problems
if you have or are being treated for lung cancer
if you have recently had or will be having surgery
if you take any medicine that may increase the risk of a certain type of irregular heartbeat (prolonged QT interval). Check with your doctor or pharmacist if you are unsure if any of your medicines may increase the risk of this type of irregular heartbeat
Some MEDICINES MAY INTERACT with sorafenib. Tell your health care provider if you are taking any other medicines, especially any of the following:

Warfarin because risk of bleeding may be increased
Carbamazepine, dexamethasone, hydantoins (eg, fosphenytoin, phenytoin), nevirapine, oral neomycin, phenobarbital, primidone, rifamycins (eg, rifabutin, rifampin), or St. John's wort because they may decrease sorafenib's effectiveness
This may not be a complete list of all interactions that may occur. Ask your health care provider if sorafenib may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use sorafenib:

Use sorafenib as directed by your doctor. Check the label on the medicine for exact dosing instructions.

An extra patient leaflet is available with sorafenib. Talk to your pharmacist if you have questions about this information.
Take sorafenib on an empty stomach at least 1 hour before or 2 hours after eating.
Swallow sorafenib whole. Do not break, crush, or chew before swallowing.
Take sorafenib with a full glass of water (8 oz [240 mL]).
Continue to take sorafenib even if you feel well. Do not miss any doses.
If you miss a dose of sorafenib, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use sorafenib.


Our advantage:

1. Rich experience.
Our company is a professional production leading factory in China in pharmaceutical area of many years, our products have exported to Germany, Spain, UK, USA, Australia, Middle East, and so on other country, and we have got very good feedback from our customers, we had Established long friendly relations of cooperation.
2. Great quality, purity and favourable.
Good quality is one of our secret success, welcome order the samples, MOQ just 10 grams.
3. Safe and fast delivery.
We have stock, so we can delivery quickly at the very day when receive the payment.
We have special way could ship 0.05kg to 3.5kg products a time. We offer melting powder into liquid service. And ship the liquid in special bottles.
4. Good after-sales service.
Tell the package update ASAP, and will try best solve when customer encountered various problems.
Welcome inquiry and order samples, we will show you our business ethics, quality/purity and safe/fast delivery.


Other Products:


Anti-inflammatory Steroids


Clobetasol Propionate

Mometasone Furoate

Betamethasone Dipropionate




Hydrocortisone Hutyrate

Betamethasone Valerate


Dexamethasone Acetate


Contact Details
Hubei Holy Biological Co., Ltd.

Contact Person: Cathy

Send your inquiry directly to us (0 / 3000)